Corrigendum to “Drug development for Autism Spectrum Disorder (ASD): Progress, challenges, and future directions. [European Neuropsychopharmacology Volume 48, July 2021, Pages 3-31]” (European Neuropsychopharmacology (2021) 48 (3–31), (S0924977X2100239X), (10.1016/j.euroneuro.2021.05.010))
- McCracken, J.T.
- Anagnostou, E.
- Arango, C.
- Dawson, G.
- McPartland, J.
- Murphy, D.
- Pandina, G.
- Veenstra-VanderWeele, J.
ISSN: 1873-7862, 0924-977X
Año de publicación: 2021
Volumen: 50
Páginas: 133-134
Tipo: Errata